He currently is the Director of the Cancer Molecular Imaging Chemistry Laboratory at MIPS where he is developing novel molecular probes, non-invasive imaging techniques, and bionanotechnology for multimodality early detection of diseases including cancer, cardiac and neurological diseases. Dr. Cheng has published over 200 articles, and he has served as a reviewer for numerous funding agencies and for over 100 research journals.